The fluoroquinolone levofloxacin triggers the transcriptional activation of iron transport genes that contribute to cell death in streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 1, 2014, Pages 247-257

  Ferrándiz, María José ^a   De La Campa, Adela G ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE IV; FLUOROQUINOLONE LEVOFLOXACIN; GYRASE INHIBITOR; HYDROGEN PEROXIDE; LEVOFLOXACIN; NOVOBIOCIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CHROMOSOME; BACTERICIDAL ACTIVITY; CELL DEATH; DNA SUPERCOILING; DOWN REGULATION; ENZYME INHIBITION; FATDCEB OPERON; FENTON REACTION; GENE ACTIVATION; GENE EXPRESSION; IRON TRANSPORT; LETHALITY; NONHUMAN; OPERON; PRIORITY JOURNAL; PROMOTER REGION; STREPTOCOCCUS PNEUMONIAE; TRANSCRIPTION INITIATION; UPREGULATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; FLUOROQUINOLONES; GENE EXPRESSION REGULATION, BACTERIAL; IRON; LEVOFLOXACIN; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE; TRANSCRIPTIONAL ACTIVATION;

EID: 84891536879     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01706-13     Document Type: Article

References (70)

1. World Health Organization. 2007. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly. Epidemiol. Rec. 82:93-104. http://www.who.int/wer/2007/wer8212.pdf.
2. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, the Active acterial Core Surveillance of the Emerging Infections Program Network. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746. http://dx.doi.org/10.1056/NEJMoa022823.
3. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG, Active Bacterial Core Surveillance of the Emerging Infection Program Network. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354:1455- 1463. http://dx.doi.org/10.1056/NEJMoa051642.
4. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR, the Active Bacterial Core Surveillance/Emerging Infection Program Network. 2010. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 201:32-41. http://dx.doi.org/10.1086/ 648593.
5. Fenoll A, Granizo JJ, Aguilar L, Gimenez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarragó D. 2009. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J. Clin. Microbiol. 47:1012-1020. http://dx.doi.org/10.1128/JCM.01454-08.
6. Fenoll A, Gimenez MJ, Vicioso MD, Granizo JJ, Robledo O, Aguilar L. 2009. Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine. J. Antimicrob. Chemother. 64:1338-1340. http://dx.doi.org/10.1093/jac/ dkp376.
7. Moore MR, Gertz JRE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197:1016-1027. http://dx.doi.org/10.1086/528996.
8. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, the Alexander Project Group. 2003. The Alexander Project 1998-2000: Susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52:229-246. http://dx.doi.org/10.1093/jac/dkg321
9. Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Ferech M, Goosens H, Doern GV. 2007. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 26:485- 490. http://dx.doi.org/10.1007/s10096-007-0321-5.
10. de la Campa AG, Ardanuy C, Balsalobre L, Pérez-Trallero E, Marimón JM, Fenoll A, Liñares J. 2009. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. Emerg. Infect. Dis. 15:905-911. http://dx.doi.org/10.3201/ eid1506.080684.
11. Fuller JD, McGeer A, Low DE. 2005. Drug-resistant pneumococcal pneumonia: Clinical relevance and approach to management. Eur. J. Clin. Microbiol. Infect. Dis. 24:780-788. http://dx.doi.org/10.1007/s10096-005-0059-x.
12. Adam HJ, Hoban DJ, Gin AS, Zhanel GG. 2009. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006. Int. J. Antimicrob. Agents 34:82-85. http://dx.doi.org/10.1016/j.ijantimicag.2009.02.002.
13. Chen DK, McGeer A, de Azavedo JC, Low DE. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233-239. http://dx.doi.org/10.1056/NEJM199907223410403.
14. Drlica K, Zhao X. 1997. DNA gyrase, topoisomerase 4, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392
15. Muñoz R, de La Campa AG. 1996. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
16. Janoir C, Zeller V, Kitzis M-D, Moreau NJ, Gutmann L. 1996. Highlevel fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob. Agents Chemother. 40:2760-2764.
17. Fernández-Moreira E, Balas D, González I, de la Campa AG. 2000. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins. Microb. Drug Resist. 6:259-267. http://dx.doi.org/10.1089/mdr.2000.6.259.
18. Tankovic J, Perichon B, Duval J, Courvalin P. 1996. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob. Agents Chemother. 40:2505-2510.
19. Houssaye S, Gutmann L, Varon E. 2002. Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:2712-2715. http://dx.doi.org/10. 1128/AAC.46.8.2712-2715.2002.
20. Champoux JJ. 2001. DNA topoisomerases: Structure, function, and mechanism. Annu. Rev. Biochem. 70:369-413. http://dx.doi.org/10.1146/annurev. biochem.70.1.369.
21. Gellert M, Mizuuchi K, ODea H, Nash HA. 1976. DNA gyrase: An enzyme that introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. U. S. A. 73:3872-3876. http://dx.doi.org/10.1073/pnas.73.11.3872.
22. Kato J, Nishimura Y, Imamura R, Niki H, Hiraga S, Suzuki H. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63:393-404. http://dx.doi.org/10.1016/0092-8674(90)90172-B.
23. Tse-Dinh Y-C. 1985. Regulation of the Escherichia coli DNA topoisomerase I gene by DNA supercoiling. Nucleic Acids Res. 13:4751-4763. http://dx.doi.org/10.1093/nar/13.13.4751.
24. Menzel R, Gellert M. 1983. Regulation of the genes for E. coli DNA gyrase: Homeostatic control of DNA supercoiling. Cell 34:105-113. http://dx.doi.org/10.1016/0092-8674(83)90140-X.
25. Menzel R, Gellert M. 1987. Modulation of transcription by DNA supercoiling: A deletion analysis of the Escherichia coli gyrA and gyrB promoters. Proc. Natl. Acad. Sci. U. S. A. 84:4185-4189. http://dx.doi.org/10. 1073/pnas.84.12.4185.
26. Menzel R, Gellert M. 1987. Fusions of the Escherichia coli gyrA and gyrB control regions to the galactokinase gene are inducible by coumermycin treatment. J. Bacteriol. 169:1272-1278.
27. Peter BJ, Arsuaga J, Breier AM, Khodursky AB, Brown PO, Cozzarelli NR. 2004. Genomic transcriptional response to loss of chromosomal supercoiling in Escherichia coli. Genome Biol. 5:R87. http://dx.doi.org/10.1186/gb-2004-5-11- r87.
28. Jeong KS, Xie Y, Hiasa H, Khodursky AB. 2006. Analysis of pleiotropic transcriptional profiles: A case study of DNA gyrase inhibition. PLoS Genet. 2:e152. http://dx.doi.org/10.1371/journal.pgen.0020152.
29. Gmüender H, Kuratli KK, Di Padova CP, Gray W, Keck W, Evers S. 2001. Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: Combined transcription and translation analysis. Genome Res. 11:28-42. http://dx.doi.org/10.1101/gr.157701.
30. Ferrándiz MJ, Martín-Galiano AJ, Schvartzman JB, de la Campa AG. 2010. The genome of Streptococcus pneumoniae is organized in topologyreacting gene clusters. Nucleic Acids Res. 38:3570-3581. http://dx.doi.org/10.1093/nar/gkq106.
31. Drlica K, Malik M, Kerns RJ, Zhao X. 2008. Quinolone-mediated bacterial death. Antimicrob. Agents Chemother. 52:385-392. http://dxdoi.org/10.1128/AAC. 01617-06.
32. Wang X, Zhao X, Malik M, Drlica K. 2010. Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death. J. Antimicrob. Chemother. 65:520-524. http://dx.doi.org/10.1093/jac/dkp486.
33. Imlay JA, Chin SM, Linn S. 1988. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240: 640-642. http://dx.doi.org/10.1126/science.2834821.
34. Dwyer DJ, Kohanski MA, Hayete B, Collins JJ. 2007. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 3:91. http://dx.doi.org/10.1038/msb4100135.
35. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. http://dx.doi.org/10.1016/j.cell.2007.06.049.
36. Wang X, Zhao X. 2009. Contribution of oxidative damage to antimicrobial lethality. Antimicrob. Agents Chemother. 53:1395-1402. http://dxdoi.org/10.1128/ AAC.01087-08.
37. Yeom J, Imlay JA, Park W. 2010. Iron homeostasis affects antibioticmediated cell death in Pseudomonas species. J. Biol. Chem. 285:22689-22695. http://dx.doi.org/10.1074/jbc.M110.127456.
38. Imlay JA. 2013. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat. Rev. Microbiol. 11:443-454. http://dx.doi.org/10.1038/nrmicro3032.
39. Foti JJ, Devadoss B, Winkler JA, Collins JJ, Walker GC. 2012. Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 336:315-319. http://dx.doi.org/10.1126/science.1219192.
40. Liu Y, Imlay JA. 2013. Cell death from antibiotics without the involvementof reactive oxygen species. Science 339:1210-1213. http://dx.doi.org/10.1126/science.1232751.
41. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K. 2013. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339:1213-1216. http://dx.doi.org/10.1126/science.1232688.
42. Dorsey-Oresto A, Lu T, Mosel M, Wang X, Salz T, Drlica K, Zhao X. 2013. YihE kinase is a central regulator of programmed cell death in bacteria. Cell Rep. 3:528-537. http://dx.doi.org/10.1016/j.celrep.2013.01.026.
43. Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ. 2008. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135:679-690. http://dx.doi.org/10.1016/j. cell.2008.09.038.
44. Lacks SA, López P, Greenberg B, Espinosa M. 1986. Identification andanalysis of genes for tetracycline resistance and replication functions in thebroad-host-range plasmid pLS1. J. Mol. Biol. 192:753-765. http://dx.doi.org/10.1016/0022-2836(86)90026-4.
45. Balsalobre L, de la Campa AG. 2008. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase 4 recombinant t genes. Antimicrob. Agents Chemother. 52:822-830. http://dx.doi.org/10.1128/AAC.00731- 07.
46. Fani F, Leprohon P, Legare D, Ouellette M. 2011. Whole genome sequencing of penicillin-resistant Streptococcus pneumoniae reveals mutations in penicillin-binding proteins and in a putative iron permease. Genome Biol. 12:R115. http://dx.doi.org/10.1186/gb-2011-12-11-r115.
47. Pruss GJ, Manes SH, Drlica K. 1982. Escherichia coli DNA topoisomerase 1 mutants: Increased supercoiling is corrected by mutations near gyrase genes. Cell 31:35-42. http://dx.doi.org/10.1016/0092-8674(82)90402-0.
48. Claverys JP, Prudhomme M, Martin B. 2006. Induction of competence regulons as a general response to stress in gram-positive bacteria. Annu. Rev. Microbiol. 60:451-475. http://dx.doi.org/10.1146/annurev.micro.60.080805.142139.
49. Luo P, Morrison DA. 2003. Transient association of an alternative sigma factor, ComX, with RNA polymerase during the period of competence for genetic transformation in Streptococcus pneumoniae. J. Bacteriol. 185:349-358. http://dx.doi.org/10.1128/JB.185.1.349-358.2003.
50. Peterson SN, Sung CK, Cline R, Desai BV, Snesrud EC, Luo P, Walling J, Li H, Mintz M, Tsegaye G, Burr PC, Do Y, Ahn S, Gilbert J, Fleischmann RD, Morrison DA. 2004. Identification of competence pheromone responsive genes in Streptococcus pneumoniae by use of DNA microarrays. Mol. Microbiol. 51:1051-1070. http://dx.doi.org/10.1046/j.1365-2958.2003.03907.x.
51. Dagkessamanskaia A, Moscoso M, Henard V, Guiral S, Overweg K, Reuter M, Martin B, Wells J, Claverys JP. 2004. Interconnection of competence, stress and CiaR regulons in Streptococcus pneumoniae: Competence triggers stationary phase autolysis of ciaR mutant cells. Mol. Microbiol. 51:1071-1086. http://dx.doi.org/10.1111/j.1365-2958.2003.03892.x.
52. Ween O, Gaustad P, Havarstein LS. 1999. Identification of DNA binding sites for ComE, a key regulator of natural competence in Streptococcus pneumoniae. Mol. Microbiol. 33:817-827. http://dx.doi.org/10.1046/j.1365-2958. 1999.01528.x.
53. Lee MS, Morrison DA. 1999. Identification of a new regulator in Streptococcus pneumoniae linking quorum sensing to competence for genetic transformation. J. Bacteriol. 181:5004-5016.
54. de Saizieu A, Gardes C, Flint N, Wagner C, Kamber M, Mitchell TJ, Keck W, Amrein KE, Lange R. 2000. Microarray-based identification of a novel Streptococcus pneumoniae regulon controlled by an autoinduced peptide. J. Bacteriol. 182:4696-4703. http://dx.doi.org/10.1128/JB.182.17.4696-4703.2000.
55. Reichmann P, Hakenbeck R. 2000. Allelic variation in a peptideinducible two-component system of Streptococcus pneumoniae. FEMS Microbiol. Lett. 190:231-236. http://dx.doi.org/10.1111/j.1574-6968.2000.tb09291.x.
56. Ulijasz AT, Andes DR, Glasner JD, Weisblum B. 2004. Regulation of iron transport in Streptococcus pneumoniae by RitR, an orphan response regulator. J. Bacteriol. 186:8123-8136. http://dx.doi.org/10.1128/JB.186.23.8123-8136.2004.
57. Muñoz R, Bustamante M, de la Campa AG. 1995. Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae isimplicated in novobiocin resistance. J. Bacteriol. 177:4166-4170.
58. García MT, Blázquez MA, Ferrándiz MJ, Sanz MJ, Silva-Martín N, Hermoso JA, de la Campa AG. 2011. New alkaloid antibiotics that target the DNA topoisomerase I of Streptococcus pneumoniae. J. Biol. Chem. 286:6402-6413. http://dx.doi.org/10.1074/jbc.M110.148148
59. Spellerberg B, Cundell DR, Sandros J, Pearce BJ, Idanpaan-Heikkila I, Rosenow C, Masure HR. 1996. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol. Microbiol. 19:803-813.
60. Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys JP. 2006. Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science 313:89-92. http://dx.doi.org/10.1126/science. 1127912.
61. Snyder M, Drlica K. 1979. DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolonic acid. J. Mol. Biol. 131:287-302.
62. Rosch JW, Gao G, Ridout G, Wang YD, Tuomanen EI. 2009. Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniae. Mol. Microbiol. 72:12-25. http://dx.doi.org/10.1111/j.1365-2958. 2009.06638.x.
63. Martín-Galiano AJ, Overweg K, Ferrándiz MJ, Reuter M, Wells JM, de la Campa AG. 2005. Transcriptional analysis of the acid tolerance response in Streptococcus pneumoniae. Microbiology 151:3935-3946. http://dx.doi.org/10.1099/mic.0.28238-0.
64. Bortoni ME, Terra VS, Hinds J, Andrew PW, Yesilkaya H. 2009. The pneumococcal response to oxidative stress includes a role for Rgg. Microbiology 155:4123-4134. http://dx.doi.org/10.1099/mic.0.028282-0.
65. Hendriksen WT, Bootsma HJ, Estevao S, Hoogenboezem T, de Jong A, de Groot R, Kuipers OP, Hermans PW. 2008. CodY of Streptococcus pneumoniae: link between nutritional gene regulation and colonization. J. Bacteriol. 190:590-601. http://dx.doi.org/10.1128/JB.00917-07.
66. Caymaris S, Bootsma HJ, Martin B, Hermans PW, Prudhomme M, Claverys JP. 2010. The global nutritional regulator CodY is an essential protein in the human pathogen Streptococcus pneumoniae. Mol. Microbiol. 78:344-360. http://dx.doi.org/10.1111/j.1365-2958.2010.07339.x.
67. Manzor ISS, Klosterman TG, Kuipers OP. 2013. Transcriptional response of Streptococcus pneumoniae to varying sources of iron and the regulatory mechanism of iron uptake system PiuBCDA, abstr OGE02. XI Eur. Meet. Mol. Biol. Pneumococcus (EuroPneumo 2013), Madrid, Spain.
68. Martín-Galiano AJ, Ferrándiz MJ, de la Campa AG. 2001. The promoter of the operon encoding the F0F1 ATPase of Streptococcus pneumoniae is inducible by pH. Mol. Microbiol. 41:1327-1338. http://dx.doi.org/10.1046/j.1365- 2958.2001.02597.x.
69. Frawley ER, Crouch ML, Bingham-Ramos LK, Robbins HF, Wang W, Wright GD, Fang FC. 2013. Iron and citrate export by a major facilitator superfamily pump regulates metabolism and stress resistance in Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 110:12054-12059. http://dx.doi.org/10.1073/pnas. 1218274110.
70. Pericone CD, Overweg K, Hermans PWM, Weiser JN. 2000. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect. Immun. 68:3990 -3997. http://dx.doi.org/10.1128/IAI.68.7.3990-3997.2000